AstraZeneca Holds a Strong Portfolio and Pipeline That Support Solid Long-Term Growth
AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that add up to a wide moat. The strong replenishment of new drugs sets up solid long-term growth.